Join TB Alliance at the virtual 52nd Union World Conference on Lung Health, taking place online on 19 - 22 October 2021. Follow our live coverage on Twitter using @TBAlliance and #UnionConf.
EVENTS CALENDARTHURSDAY, OCTOBER 14
Partner Event | Working Group on New Drugs Annual Meeting
9:00AM-12:00PM ET | 15:00-18:00 CEST
TB Alliance will be presenting updates to its pipeline at the Stop TB Partnership’s Working Group on New Drugs (WGND) Annual Meeting. The 2021 WGND Annual Meeting offers a neutral platform to all those actively working in TB drug research and development to provide stakeholders a full understanding of the progress, challenges, and critical issues facing the global TB drug pipeline. For meeting information and registration, please click here.
E-Poster Presentation | No adverse effects on male reproductive hormones in patients treated with pretomanid-containing regimens
All e-posters will be available online at 4:00 ET | 10:00 CEST
TB Alliance summarizes reports on levels of male hormones from four clinical studies evaluating both drug-susceptible and drug-resistant patients. Please see the online program for additional details.
Partner Event | Parliamentary action to end TB during a pandemic
5:00-8:30 ET | 11:00-14:30 CEST | Live Channel
The Global TB Caucus will host a session that will feature insights from MPs on building high-level political commitment, multi-sectoral collaboration and accountability, resource mobilization and sustainable financing, and future strategies and actions leading up to the High-Level Meeting in 2023. This session will feature participation from TB Alliance and will be broadcast on the Union LIVE Channel.
Community Connect Session | Advancing GPP compliance through innovative online dissemination and learning models
12:00-12:45 ET | 18:00-18:45 CEST | CC Channel 3
Participants in this Community Connect session will discuss how political environments for community-led advocacy can influence policy through the lens of Good Participatory Practices. TB Alliance will join partners for this event and will share updates on our Community Engagement program. Hosted by AVAC, this session will be on Community Connect Channel 3. Please see the online program for additional details.
The BPaL Regimen: update on clinical and operational research
10:30-11:50 ET | 16:30-17:50 CEST | Channel 3
TB Alliance will join partners for a symposium to discuss the latest clinical evidence from the ZeNix and TB-PRACTECAL clinical trials, as well as preliminary results in countries conducting operational research including Ukraine, South Africa and the Philippines. This virtual session will be on Channel 3. Please see the online program for additional details.
Symposium | TB-PRACTECAL: trial results and next steps
9:00-10:20 ET | 15:00-16:20 CEST | Channel 4
TB Alliance is a proud partner of TB-PRACTECAL, a Phase 2/3 adaptive, open-label, non-inferiority, randomized controlled trial examining 6-month treatment regimens for rifampicin-resistant TB sponsored by Médecins Sans Frontières. This virtual Symposia Session will report the initial trial results on Channel 4. Please see the online program for additional details.
Community Connect Session | Researchers Sharing with Communities: trial results and next steps
11:00-11:45 ET | 17:00-17:45 CEST | CC Channel 2
This Community Connect session will discuss recent innovations in TB, tobacco control, COVID-19, lung health and other non-communicable diseases. Hosted by the Treatment Action Group, TB Alliance will join panelists for this event and will share updates on the ZeNix clinical trial results. This session will be on Community Connect Channel 2. Please see the online program for additional details.